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Absorption of organic anions (phenol red, bromphenol blue and bromosulphonphthalein) has 
been studied after their application to rat liver surface in-vivo, employing a cylindrical glass 
cell (i.d. 9 mm, area 0.64 cm2).   Every drug appeared gradually in the blood with the peak 
level at about 1 h, after which its concentration declined slowly.   Absorbed model drug was 
efficiently excreted into the bile.   These observations appear to indicate the possibility of 
drug absorption from liver surface membrane.   Absorption ratios of model drugs were 
estimated to be more than 59 % in 6 h.   As to phenol red, its biliary recovery and 





Liver plays an important role in drug disposition in the body, so that there is an increasing 
interest in improving treatment of liver diseases.   It is desired that the administered drug 
distributes largely into the target site in the liver, as proposed to treat liver diseases e.g. 
localized tumor.   Normal routes of drug administration have difficulty in achieving a local 
site of action in the liver. 
     Although direct drug application to the liver surface should yield local drug distribution, 
drug absorption from liver surface has not been reported in literature. 
     In the present study, we have examined the absorption of organic anions (phenol red 
(PR), bromphenol blue (BPB), bromosulphonphthalein (BSP)) as model drugs, after 
application to rat liver surface. 
 
 
Materials and methods 
Chemicals. 
PR and BPB were purchased from Nacalai Tesque, Inc. (Kyoto, Japan).   BSP was obtained 




All animal experiments in the present study conformed to the Guideline for Animal 
Experimentation in Nagasaki University. 
     Male Wistar rats (230-250 g) were anesthetized with sodium pentobarbital (50 mg kg-1, 
i.p.) and the left femoral artery was cannulated with a polyethylene tube (i.d. 0.5 mm, o.d. 0.8 
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mm, Dural Plastics, Dural, Australia).   After the middle abdomen was cut open for about 3 
cm, the common bile duct was cannulated with a polyethylene tube (i.d. 0.28 mm, o.d. 0.61 
mm, Becton Dickinson & Co., Parsippany, NJ, USA).  The body temperature of rats was 
kept at 37｡C by a heat lamp during the experiment.   The test solution was prepared in an 
isotonic phosphate buffer (pH 7.4) to yield a concentration of 1 mg/0.1 mL, and administered 
as follows.     
     Application to rat liver surface: A cylindrical glass cell (i.d. 9 mm, area 0.64 cm2) was 
attached to rat liver surface at the area of left lobe with Aron Alpha (Sankyo Co. Ltd, Tokyo, 
Japan).   The drug solution (0.1 mL) was added to the glass cell directly.   The top of the 
glass cell was sealed by a piece of aluminum foil to prevent evaporation of the applied 
solution. 
     i.v. administration: The drug solution (0.1 mL) was injected into the jugular vein. 
     Direct injection into rat liver: The test solution (0.1 mL) was directly injected over 20 
sec into the center of liver left lobe by using a syringe at a depth of 3 mm.   The midpoint of 
the injection time was defined to be time 0. 
     After application of the drug solution, 200 mL of blood sample was collected at 
selected times from the heparinized cannula inserted into the femoral artery over 4 or 6 h and 
centrifuged at 15000 rpm for 5 min.   Bile samples were collected at appropriate time 
intervals for 4 or 6 h.   At 4 or 6 h after the application, urine was collected from the bladder 
directly by syringe.   Following application to rat liver surface, the remaining dose solution 
in the glass cell was withdrawn at 6 h after dosing. 
 
Analytical Method. 
The concentrations of model drugs in plasma, bile, urine and remaining solution in glass cell 
were determined as follows.    
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     PR: The concentration of free PR was determined spectrophotometrically at 560 nm 
after dilution with a 1 M NaOH solution.   The total concentration of free PR and its 
metabolite was measured in the same manner after they were subjected to acid hydrolysis (1 
M HCl at 100｡C for 30 min) (Hart & Schanker 1966).   The concentration of PR metabolite 
was estimated from the difference between these values. 
     BPB: The concentration of BPB was determined spectrophotometrically at 600 nm after 
dilution with an isotonic phosphate buffer (pH 7.4) (Takada et al 1974). 
     BSP: The concentration of BSP was determined spectrophotometrically at 580 nm after 
dilution with a 0.1 M NaOH solution (Frezza et al 1974). 
 
Calculation of Moment Parameters. 
 The plasma concentration profiles and biliary excretion rate-time curves of free PR and 
its metabolite, BPB and BSP were analyzed based on statistical moment theory.   Moment 
parameters for plasma concentration profile (AUCp, MRTp) and those for biliary excretion 
rate-time curve (AUCb, MRTb) are calculated by numeral integration using a linear 
trapezoidal formula and extrapolation to infinite time based on a monoexponential equation 
(Yamaoka et al 1978).   As to PR, moment parameters for the biliary excretion rate-time 




Results and discussion 
 The main purpose of this study is to examine the possibility of drug absorption from the 




     We selected three organic anions (PR, BPB and BSP) as a model drug because their 
disposition characteristics in liver had been investigated (Klaassen & Watkins III 1984; 
Tiribelli et al 1986, 1990; Hart & Schanker 1966; Moller & Sheikh 1983; Kakutani et al 
1992).    
     Fig. 1a shows the plasma concentration profiles of model drugs after application to rat 
liver surface at a dose of 1 mg.   Every model drug appeared in the blood at a low 
concentration (< 6.5 mg mL-1).   This observation suggests the occurrence of drug 
absorption from rat liver surface membrane which seems to act as an effective barrier for 
several molecules to some extent.   The plasma concentration of model drugs after 
application to rat liver surface reached a maximum at about 1 h after dosing and decreased 
gradually (Fig. 1a), representing the increased residence time in plasma as compared with i.v. 
administration (Fig. 1b).   The prolongation of plasma concentration as compared with i.v. 
administration was marked in BPB and BSP (Figs. 1a and 1b). 
 
< Fig. 1 > 
 
     After absorption from rat liver surface, every model drug was excreted into the bile, as 
shown in Fig. 2a.   Similarly to the plasma concentration profile, the biliary excretion rate 
after application to rat liver surface showed a delayed pattern as compared with that of i.v. 
administration (Fig. 2b).   The biliary excretion rate patterns differed among the model 
drugs.   As to PR, its metabolite (PR-glucuronic acid conjugate) (Hart & Schanker 1966) 
was also excreted into the bile.    
 




     Tables 1 and 2 list the recovery (% dose) of model drugs in the bile, urine and glass cell 
on various administration routes.   The extents of absorption were calculated, from the dose 
and the amount recovered in the glass cell after 6 h, as 91.8 % (PR), 71.6 % (BPB) and 
58.6 % (BSP).    
     PR and its metabolite were excreted into both bile and urine on every administration 
route (Table 1), whereas BPB and BSP were predominantly excreted into the bile (Table 2).   
The biliary recovery and metabolism ratios of PR after application to rat liver surface were 
broadly similar to those of i.v. administration (Table 1).   It is supposed that the drug 
elimination and metabolism processes are not affected by application to liver surface.  
     Moment parameters are free from the complexities of a pharmacokinetic model, and 
thus AUCp and MRTp can be appropriate parameters for evaluating roughly the drug 
absorbability from liver surface.   Tables 2 and 3 summarize the moment parameters for 
model drugs after application to rat liver surface.   The AUCp and MRTp for BSP after 
application to rat liver surface could not be calculated exactly owing to its low plasma 
concentration. 
     The AUCp values for PR and BPB after application to rat liver surface, which contain 
large errors, were roughly equal to those of i.v. administration (Tables 2 and 3), supporting the 
good absorbability from rat liver surface.   As expected, the MRTp values for PR and BPB 
after application to rat liver surface were fairly larger than those of i.v. administration (Tables 
2 and 3). 
     The ratio of AUCb,f for PR and BPB values following application to rat liver surface to 
those of i.v. administration were 89.9 and 70.5 % respectively, which were in good agreement 
with recovery data estimates of absorption (Tables 2 and 3).   The MRTb,f and MRTb,m for 
PR after application to rat liver surface were by respectively, 2.7 and 2.4 times larger than 
those of i.v. administration (Table 3).   Similarly, a marked increase in MRTb values was 
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seen with the application of BPB and BSP to rat liver surface (Table 2).   From these results, 
the drug concentration in liver after application to rat liver surface seems to be sustained as 
compared with that of i.v. administration, although its concentration was not determined 
directly. 
     We also examined the disposition characteristics of model drugs after direct injection 
into rat liver by use of a syringe, for comparison.   In this case, the plasma concentration 
profiles and biliary excretion rate patterns of every model drug (data not shown) were 
unaltered, as compared with those of i.v. administration (Figs. 1b and 2b).   The in-vivo 
behaviours of model drugs after direct injection into rat liver were considered to be basically 
similar to those of i.v. administration, judging from the pharmacokinetic parameters (Tables 
1-3).   It is suggested that the direct injection route is not suitable for target site-specific 
drug delivery to the liver with a high blood flow, because directly injected drug was rapidly 
cleared from the injection site, followed by drainage into the systemic circulation. 
     In conclusion, the present paper provides initial evidence of the drug absorption from 
rat liver surface.   Such information should be useful in the development of new 
administration route for drug delivery to the target site in liver.   However, further work is 
required to elucidate the mechanism for drug absorption and to examine the drug absorption 
from the diseased liver surface for clinical application.    
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